Hiroyuki Uchida

12.0k total citations
366 papers, 6.8k citations indexed

About

Hiroyuki Uchida is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, Hiroyuki Uchida has authored 366 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Psychiatry and Mental health, 79 papers in Pharmacology and 52 papers in Molecular Biology. Recurrent topics in Hiroyuki Uchida's work include Schizophrenia research and treatment (139 papers), Treatment of Major Depression (75 papers) and Bipolar Disorder and Treatment (56 papers). Hiroyuki Uchida is often cited by papers focused on Schizophrenia research and treatment (139 papers), Treatment of Major Depression (75 papers) and Bipolar Disorder and Treatment (56 papers). Hiroyuki Uchida collaborates with scholars based in Japan, Canada and United States. Hiroyuki Uchida's co-authors include Takefumi Suzuki, Masaru Mimura, Koichiro Watanabe, David C. Mamo, Hiroyoshi Takeuchi, Ariel Graff‐Guerrero, Bruce G. Pollock, Benoit H. Mulsant, Haruo Kashima and W. Wolfgang Fleischhacker and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hiroyuki Uchida

344 papers receiving 6.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroyuki Uchida Japan 42 3.4k 1.1k 975 965 633 366 6.8k
Chunbo Li China 43 3.7k 1.1× 559 0.5× 1.4k 1.5× 550 0.6× 2.1k 3.4× 326 8.3k
Chi‐Un Pae South Korea 42 2.4k 0.7× 1.8k 1.5× 748 0.8× 987 1.0× 564 0.9× 310 6.9k
Chuanyue Wang China 43 2.2k 0.6× 515 0.5× 812 0.8× 526 0.5× 1.3k 2.1× 283 5.7k
Davangere P. Devanand United States 50 5.0k 1.5× 1.3k 1.2× 663 0.7× 506 0.5× 1.8k 2.8× 204 9.7k
Ashwin A. Patkar United States 44 2.0k 0.6× 1.8k 1.6× 899 0.9× 972 1.0× 598 0.9× 282 7.2k
Jae‐Min Kim South Korea 46 1.8k 0.5× 782 0.7× 2.0k 2.1× 1.1k 1.1× 686 1.1× 446 9.0k
Paul J. Perry United States 44 2.3k 0.7× 1.0k 0.9× 699 0.7× 639 0.7× 438 0.7× 155 6.0k
George T. Grossberg United States 49 3.8k 1.1× 3.2k 2.8× 734 0.8× 1.3k 1.3× 880 1.4× 274 10.2k
Peter P. Zandi United States 55 3.7k 1.1× 1.0k 0.9× 1.4k 1.4× 1.6k 1.7× 621 1.0× 202 11.4k
Maria C. Norton United States 49 4.2k 1.2× 580 0.5× 1.1k 1.1× 550 0.6× 819 1.3× 149 8.7k

Countries citing papers authored by Hiroyuki Uchida

Since Specialization
Citations

This map shows the geographic impact of Hiroyuki Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Uchida more than expected).

Fields of papers citing papers by Hiroyuki Uchida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Uchida. The network helps show where Hiroyuki Uchida may publish in the future.

Co-authorship network of co-authors of Hiroyuki Uchida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Uchida. A scholar is included among the top collaborators of Hiroyuki Uchida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Uchida. Hiroyuki Uchida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Kan, Hirohito, Shiori Honda, Masataka Wada, et al.. (2024). Alterations in subcortical magnetic susceptibility and disease-specific relationship with brain volume in major depressive disorder and schizophrenia. Translational Psychiatry. 14(1). 164–164. 4 indexed citations
4.
5.
Nishi, Akira, Kyosuke Sawada, Hiroyuki Uchida, Masaru Mimura, & Hiroyoshi Takeuchi. (2022). Antipsychotic Monotherapy for Major Depressive Disorder: A Systematic Review and Meta-Analysis. Pharmacopsychiatry. 56(1). 5–17. 2 indexed citations
6.
Miyazaki, Tomoyuki, Hiroki Abe, Hiroyuki Uchida, & Takuya Takahashi. (2021). Translational medicine of the glutamate AMPA receptor. Proceedings of the Japan Academy Series B. 97(1). 1–21. 7 indexed citations
7.
Takeuchi, Hiroyoshi, et al.. (2020). Prescription patterns of psychotropics in patients receiving synthetic glucocorticoids. Acta Psychiatrica Scandinavica. 142(3). 242–248. 2 indexed citations
8.
Noda, Yoshihiro, Ryosuke Tarumi, Shiori Honda, et al.. (2020). White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 100. 109871–109871. 22 indexed citations
9.
Ogyu, Kamiyu, Yoshihiro Noda, Kazunari Yoshida, et al.. (2020). Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia. Neuropsychopharmacology Reports. 40(2). 138–149. 5 indexed citations
10.
Suzuki, Takefumi, et al.. (2019). Factors Associated With Delirium Following Electroconvulsive Therapy. Journal of Ect. 35(4). 279–287. 25 indexed citations
11.
Sawada, Kyosuke, Kazunari Yoshida, Yuya Mizuno, et al.. (2018). Impact of subjective vs. objective remission status on subjective cognitive impairments in depression. Journal of Affective Disorders. 246. 99–104. 10 indexed citations
12.
Sakurai, Hitoshi, Takefumi Suzuki, Kimio Yoshimura, Masaru Mimura, & Hiroyuki Uchida. (2017). Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology. 234(16). 2453–2461. 60 indexed citations
13.
Takahashi, Kana, et al.. (2017). Identification of common words to improve self-confidence in Japanese students with subthreshold depression. International Journal of Adolescent Medicine and Health. 31(3). 9 indexed citations
14.
Ueno, Fumihiko, Shinichiro Nakajima, Takefumi Suzuki, et al.. (2015). Whether to Increase or Maintain Dosage of Mirtazapine in Early Nonimprovers With Depression. The Journal of Clinical Psychiatry. 76(4). 434–439. 3 indexed citations
15.
Zohar, Joseph, Stephen M. Stahl, Hans‐Jürgen Möller, et al.. (2015). A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. European Neuropsychopharmacology. 25(12). 2318–2325. 110 indexed citations
16.
Nakajima, Shinichiro, Hiroyuki Uchida, Robert R. Bies, et al.. (2015). Dopamine D2/3Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial. Schizophrenia Bulletin. 42(1). sbv106–sbv106. 18 indexed citations
17.
Ishida, Takuto, Takefumi Suzuki, Koichiro Watanabe, et al.. (2014). Prophylactic use of heparin for deep vein thrombosis in restrained psychiatric patients: a chart review. General Hospital Psychiatry. 36(6). 690–693. 9 indexed citations
18.
Suzuki, Takefumi, Hiroyuki Uchida, Juri Saruta, et al.. (2014). Effects of Weekly One-Hour Hatha Yoga Therapy on Resilience and Stress Levels in Patients with Schizophrenia-Spectrum Disorders: An Eight-Week Randomized Controlled Trial. The Journal of Alternative and Complementary Medicine. 20(11). 823–830. 52 indexed citations
19.
Uchida, Hiroyuki, et al.. (2009). Persistence and compliance to antidepressant treatment in patients with depression: A chart review. BMC Psychiatry. 9(1). 38–38. 150 indexed citations
20.
Uchida, Hiroyuki, et al.. (2005). Combined Treatment With Sulpiride and Paroxetine for Accelerated Response in Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology. 25(6). 545–551. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunbo Li Breakdown of academic impact, for papers by Chi‐Un Pae Breakdown of academic impact, for papers by Chuanyue Wang Breakdown of academic impact, for papers by Davangere P. Devanand Breakdown of academic impact, for papers by Ashwin A. Patkar Breakdown of academic impact, for papers by Jae‐Min Kim Breakdown of academic impact, for papers by Paul J. Perry Breakdown of academic impact, for papers by George T. Grossberg Breakdown of academic impact, for papers by Peter P. Zandi Breakdown of academic impact, for papers by Maria C. Norton
Rankless by CCL
2026